mk-5475
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 18, 2019 (NCT03744637)
Timeline
Indications
Mechanism of action
NPR1 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05612035 | Phase 2 | Dec 19, 2022 | Merck |
| NCT06777602 | Phase 1 | Aug 15, 2022 | Merck |
| NCT04732221 | Phase 2/Phase 3 (Phase 3) | May 19, 2021 | Merck |
| NCT04425733 | Phase 1 | Jul 7, 2020 | Merck |
| NCT04370873 | Phase 1 | May 27, 2020 | Merck |
| NCT03744637 | Phase 1 | Jan 18, 2019 | Merck |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 6 | 6 | 3 | 2019 |
1 organizations
Page 1 / 1